Key result
Positive CAD trials achieve higher publication rates than negative trials, highlighting publication bias.
Answers are grounded in this paper and cite their sources.
Publication bias is present in coronary artery disease clinical trials, with positive outcomes published at a higher rate than negative results, which may skew evidence-based decision making.
Positive outcomes had a higher publication rate compared with the negative results. Identification of this bias is critical in addressing the impact it could have on the practice of evidence-based medicine. If negative results are not being published, then this pushes physicians to rely on positive results more heavily, thereby skewing evidence-based decision making. This in turn impacts decisions that affect the quality of care.
No takes yet. Share an insight, caveat, or question.
Shukla et al. (2026) conducted a review in Coronary Artery Disease. Clinical trials with positive outcomes vs. Clinical trials with negative outcomes was evaluated on Publication rate. Clinical trials with positive outcomes in coronary artery disease had a higher publication rate compared with negative results, indicating a publication bias that may skew evidence-based medicine.
Synapse has enriched 10 related papers. Consider them for comparative context: